BioRestorative registers $11.5 million of shares for public offering

Bookrunner Aegis Capital assists; deal will include five-year warrants

By Devika Patel

Knoxville, Tenn., June 3 – BioRestorative Therapies, Inc. will conduct a public offering of common stock and warrants with a 30-day greenshoe, according to a Form S-1 filed Wednesday with the Securities and Exchange Commission.

The company has registered up to $11.5 million of stock and up to $14,375,000 of underlying stock for the five-year warrants.

Aegis Capital Corp. is the bookrunning manager.

Proceeds will be used to submit an IND application for brtxDISC to the FDA, for research and development and for general corporate and working capital purposes.

Based in Jupiter, Fla., BioRestorative is a life sciences company focused on cellular therapies for various personal medical applications.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.